Public disclosures

VNRX insider disclosures

Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.

Advertisement
More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSourceFollow
Reynolds Cameron John

President and CEO · Director · VOLITIONRX LTD

VNRX

VOLITIONRX LTD

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 185781 · SEC code covers open-market or private transactions · On April 28, 2026, the Issuer effected a one-for-20 reverse stock split of its issued and outstanding common stock and made proportionate retroactive adjustments to its outstanding equity awards to the extent required including with respect to then-outstanding RSUs (the "Reverse Split"). No fractional shares were issued in connection with the Reverse Split, and each holder who otherwise would have been entitled to receive a fractional share received one whole share of common stock in lieu of such fractional share. Accordingly, the amount of securities beneficially owned directly and indirectly in column 5 of Table 1 has been adjusted to reflect the impact of the Reverse Split.

2026-11-192026-11-20

≈ $6,848.00

40,000 shares/units

SEC 4Follow

Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.

Advertisement